Fundz

Galmed Pharmaceuticals to acquire Colospan for GI focus

PUBLIC · EOCNJun 08, 2026

Acquiring Company

Galmed Pharmaceuticals Ltd

Acquired Company

Colospan Ltd

Tel Aviv DistrictRaipurBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharmaManufacturingBiotechnologyHealth CareMedicalMedical Device

Description

Galmed Pharmaceuticals has announced its acquisition of Colospan, aimed at creating a GI-focused platform. Colospan will become a wholly owned subsidiary, enhancing Galmed's capabilities with its innovative medical device technologies. The acquisition is expected to close in Q2 2026 and has been unanimously approved by both companies' boards.

Company Information

Company

Galmed Pharmaceuticals Ltd

Location

Tel Aviv District, Israel

About

Galmed Pharmaceuticals Ltd. is a biopharmaceutical company focused on developing innovative therapies for liver diseases and other conditions. The company's expertise spans drug development and corporate management, enhancing its capabilities in the healthcare sector. Galmed is listed on the NASDAQ and is committed to addressing unmet medical needs through its research and development efforts.

Fundz sees it the moment Galmed Pharmaceuticals Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Yohai
Senior decision-maker at this company
••••••••@••••••••

See Yohai's verified email →

Guy
Senior decision-maker at this company
••••••••@••••••••

See Guy's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Galmed Pharmaceuticals Ltd's next move

Learn about Strategic plan

Frequently asked

Who acquired Colospan Ltd?

Colospan Ltd was acquired by Galmed Pharmaceuticals Ltd, based in Tel Aviv District. The deal was reported on June 8, 2026. Galmed Pharmaceuticals Ltd. is a biopharmaceutical company focused on developing innovative therapies for liver diseases and other conditions. Galmed Pharmaceuticals Ltd is publicly traded (EOCN) and operates in Biotechnology.

When did Galmed Pharmaceuticals Ltd acquire Colospan Ltd?

Galmed Pharmaceuticals Ltd's acquisition of Colospan Ltd was reported on June 8, 2026. Galmed Pharmaceuticals has announced its acquisition of Colospan, aimed at creating a GI-focused platform. Colospan will become a wholly owned subsidiary, enhancing Galmed's capabilities with its innovative medical device technologies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Colospan Ltd do?

Colospan Ltd. is a commercial-stage medical device company specializing in innovative solutions for colorectal surgery complications, particularly addressing anastomotic leaks. It is privately held, operating in Manufacturing, and is based in Raipur.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.